Antimicrobial sulfated glycans: Structure and function

Current Topics in Medicinal Chemistry

Volumn 17, Issue 3, 2017, Pages 319-330

  Pomin, Vitor H ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Antibacterial; Antifungal; Antiprotozoan; Antiviral; Carbohydrate based drug development; Carbohydrate based drug discovery; Glycosaminoglycans; Sulfated glycans

Indexed keywords

CHONDROITIN SULFATE; GLYCOSAMINOGLYCAN; ANTIINFECTIVE AGENT; POLYSACCHARIDE; SULFATE;

ANTIMICROBIAL ACTIVITY; ARTICLE; CYTOTOXICITY; DEPOLYMERIZATION; DRUG MECHANISM; ENZYMATIC DEGRADATION; INTERFEROMETRY; LIQUID CHROMATOGRAPHY; MOLECULAR INTERACTION; MOLECULAR SIZE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN STRUCTURE; CHEMISTRY; STRUCTURE ACTIVITY RELATION;

ANTI-INFECTIVE AGENTS; POLYSACCHARIDES; STRUCTURE-ACTIVITY RELATIONSHIP; SULFATES;

EID: 85011583564     PISSN: 15680266     EISSN: 18734294     Source Type: Journal    
DOI: 10.2174/1568026615666150605104444     Document Type: Article

References (68)

1. Pomin, V. H. Sulfated glycans in inflammation. Eur. J. Med. Chem., 2015, 92C, 353-369
2. Nelson, R. M.; Venot, A.; Bevilacqua, M. P.; Linhardt, R. J.; Stamenkovic, I. Carbohydrate-protein interactions in vascular biology. Annu. Rev. Cell Dev. Biol., 1995, 11, 601-631
3. Afratis, N.; Gialeli, C.; Nikitovic, D.; Tsegenidis, T.; Karousou, E.; Theocharis, A. D.; Pavão, M. S.; Tzanakakis, G. N.; Karamanos, N. K. Glycosaminoglycans: key players in cancer cell biology and treatment. FEBS J., 2012, 279(7), 1177-1197
4. Sasisekharan, R.; Shriver, Z.; Venkataraman, G.; Narayanasami, U. Roles of heparan-sulphate glycosaminoglycans in cancer. Nat. Rev. Cancer., 2002, 2(7), 521-528
5. Bourin, M. C.; Lindahl, U. Glycosaminoglycans and the regulation of blood coagulation. Biochem. J., 1993, 289(Pt 2), 313-330
6. Zancan, P.; Mourão, P. A. Venous and arterial thrombosis in rat models: dissociation of the antithrombotic effects of glycosaminoglycans. Blood Coagul. Fibrinolysis., 2004, 15(1), 45-54
7. de Mattos, D. A.; Stelling, M. P.; Tovar, A. M.; Mourão, P. A. Heparan sulfates from arteries and veins differ in their antithrombin-mediated anticoagulant activity. J. Thromb. Haemost., 2008, 6(11), 1987-1990
8. Jinno, A.; Park, P. W. Role of glycosaminoglycans in infectious disease. Methods Mol. Biol., 2015, 1229, 567-585
9. Sawitzky, D. Protein-glycosaminoglycan interactions: infectiological aspects. Med. Microbiol. Immunol., 1996, 184(4), 155-161
10. Baron, M. J.; Wong, S. L.; Nybakken, K.; Carey, V. J.; Madoff, L. C. Host glycosaminoglycan confers susceptibility to bacterial infection in Drosophila melanogaster. Infect. Immun., 2009, 77(2), 860-866
11. Chang, Y. C.; Wang, Z.; Flax, L. A.; Xu, D.; Esko, J. D.; Nizet, V.; Baron, M. J. Glycosaminoglycan binding facilitates entry of a bacterial pathogen into central nervous systems. PLoS Pathog., 2011, 7(6), e1002082
12. Sava, I. G.; Zhang, F.; Toma, I.; Theilacker, C.; Li, B.; Baumert, T. F.; Holst, O.; Linhardt, R. J.; Huebner, J. Novel interactions of glycosaminoglycans and bacterial glycolipids mediate binding of enterococci to human cells. J. Biol. Chem., 2009, 284(27), 18194-18201
13. Wadström, T.; Ljungh, A. Glycosaminoglycan-binding microbial proteins in tissue adhesion and invasion: key events in microbial pathogenicity. J. Med. Microbiol., 1999, 48(3), 223-233
14. Leistner, C. M.; Gruen-Bernhard, S.; Glebe, D. Role of glycosaminoglycans for binding and infection of hepatitis B virus. Cell. Microbiol., 2008, 10(1), 122-133
15. Hallak, L. K.; Spillmann, D.; Collins, P. L.; Peeples, M.E. Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection. J. Virol., 2000, 74(22), 10508-10513
16. Bose, S.; Banerjee, A. K. Role of heparan sulfate in human parainfluenza virus type 3 infection. Virology., 2002, 298(1), 73-83
17. Wuppermann, F. N.; Hegemann, J. H.; Jantos, C. A. Heparan sulfate-like glycosaminoglycan is a cellular receptor for Chlamydia pneumoniae. J. Infect. Dis., 2001, 184(2), 181-187
18. Patel, M.; Yanagishita, M.; Roderiquez, G.; Bou-Habib, D. C.; Oravecz, T.; Hascall, V. C.; Norcross, M. A. Cell-surface heparan sulfate proteoglycan mediates HIV-1 infection of T-cell lines. AIDS Res. Hum. Retroviruses., 1993, 9(2), 167-174
19. Srinoulprasert, Y.; Kongtawelert, P.; Chaiyaroj, S. C. Chondroitin sulfate B and heparin mediate adhesion of Penicillium marneffei conidia to host extracellular matrices. Microb. Pathog., 2006, 40(3), 126-132
20. Muller, H. M.; Reckmann, I.; Hollingdale, M. R.; Bujard, H.; Robson, K. J.; Crisanti, A. Thrombospondin-related anonymous protein (TRAP) of Plasmodium falciparum binds specifically to sulfated glycoconjugates and to HepG2 hepatoma cells, suggesting a role for this molecule in sporozoite invasion of hepatocytes. EMBO J., 1993, 12, 2881-2889
21. Yokoyama, N.; Okamura, M.; Igarashi, I. Erythrocyte invasion by Babesia parasites: current advances in the elucidation of the molecular interactions between the protozoan ligands and host receptors in the invasion stage. Vet. Parasitol., 2006, 138(1-2), 22-32
22. Vivès, R. R.; Imberty, A.; Sattentau, Q. J.; Lortat-Jacob, H. Heparan sulfate targets the HIV-1 envelope glycoprotein gp120 coreceptor binding site. J. Biol. Chem., 2005, 280(22), 21353-21357
23. Nagumo, T.; Hoshino, H. Heparin inhibits infectivity of human immunodeficiency virus in vitro. Jpn J. Cancer Res., 1988, 79(1), 9-11
24. Müller, G.; Kramer, A. In vitro action of a combination of selected antimicrobial agents and chondroitin sulfate. Chem. Biol. Interact., 2000, 124(2), 77-85
25. Bergefall, K.; Trybala, E.; Johansson, M.; Uyama, T.; Naito, S.; Yamada, S.; Kitagawa, H.; Sugahara, K.; Bergström, T. Chondroitin sulfate characterized by the E-disaccharide unit is a potent inhibitor of herpes simplex virus infectivity and provides the virus binding sites on gro2C cells. J. Biol. Chem., 2005, 280(37), 32193-32199
26. Kim, E.; Okumura, M.; Sawa, H.; Miyazaki, T.; Fujikura, D.; Yamada, S.; Sugahara, K.; Sasaki, M.; Kimura, T. Paradoxical effects of chondroitin sulfate-E on Japanese encephalitis viral infection. Biochem. Biophys. Res. Commun., 2011, 409(4), 717-722
27. Im, A.R.; Kim, J.Y.; Kim, H.S.; Cho, S.; Park, Y.; Kim, Y.S. Wound healing and antibacterial activities of chondroitin sulfateand acharan sulfate-reduced silver nanoparticles. Nanotechnology., 2013, 24(39), 395102
28. Pomin, V.H. Holothurian fucosylated chondroitin sulfate. Mar. Drugs., 2014, 12(1), 232-254
29. Lian, W.; Wu, M.; Huang, N.; Gao, N.; Xiao, C.; Li, Z.; Zhang, Z.; Zheng, Y.; Peng, W.; Zhao, J. Anti-HIV-1 activity and structureactivity-relationship study of a fucosylated glycosaminoglycan from an echinoderm by targeting the conserved CD4 induced epitope. Biochim. Biophys. Acta., 2013, 1830(10), 4681-4691
30. Huang, N.; Wu, M.Y.; Zheng, C.B.; Zhu, L.; Zhao, J.H.; Zheng, Y.T. The depolymerized fucosylated chondroitin sulfate from sea cucumber potently inhibits HIV replication via interfering with virus entry. Carbohydr. Res., 2013, 380, 64-69
31. Bastos, M.F.; Albrecht, L.; Kozlowski, E.O.; Lopes, S.C.; Blanco, Y.C.; Carlos, B.C.; Castiñeiras, C.; Vicente, C.P.; Werneck, C.C.; Wunderlich, G.; Ferreira, M.U.; Marinho, C.R.; Mourão, P.A.; Pavão, M.S.; Costa, F.T. Fucosylated chondroitin sulfate inhibits Plasmodium falciparum cytoadhesion and merozoite invasion. Antimicrob. Agents Chemother., 2014, 58(4), 1862-1871
32. Rostand, K.S.; Esko, J.D. Microbial adherence to and invasion through proteoglycans. Infect. Immun., 1997, 65(1), 1-8
33. Trowbridge, J.M.; Gallo, R.L. Dermatan sulfate: new functions from an old glycosaminoglycans. Glycobiology., 2002, 12(9), 117R-125R
34. Brown, E.L.; Wooten, R.M.; Johnson, B.J.; Iozzo, R.V.; Smith, A.; Dolan, M.C.; Guo, B.P.; Weis, J.J.; Höök, M. Resistance to Lyme disease in decorin-deficient mice. J. Clin. Invest., 2001, 107(7), 845-852
35. Schmidtchen, A.; Frick, I.M.; Björck, L. Dermatan sulphate is released by proteinases of common pathogenic bacteria and inactivates antibacterial alpha-defensin. Mol. Microbiol., 2001, 39(3), 708-713
36. Rabestein, D.L. Heparin and heparan sulfate: structure and function. Nat. Prod. Rep., 2002, 19(3), 312-331
37. Sasisekharan, R.; Venkataraman, G. Heparin and heparan sulfate: biosynthesis, structure and function. Curr. Opin. Struct. Biol., 2000, 4(6), 626-631
38. Santos, G.R.; Tovar, A.M.; Capillé, N.V.; Pereira, M.S.; Pomin, V.H.; Mourão, P.A. Structural and functional analyses of bovine and porcine intestinal heparins confirm they are different drugs. Drug Discov. Today., 2014, 19(11), 1801-1807
39. Glauser, B.F.; Vairo, B.C.; Oliveira, S.N.; Cinelli, L.P.; Pereira, M.S.; Mourão, P.A. Structure and haemostatic effects of generic versions of enoxaparin available for clinical use in Brazil: similarity to the original drug. Thromb. Haemost., 2012, 107(2), 302-314
40. Weitz, J.I. Low-molecular-weight heparins. N. Engl. J. Med., 1997, 337(10), 688-698
41. Rosett, W.; Hodges, G.R. Antimicrobial activity of heparin. J. Clin. Microbiol., 1980, 11(1), 30-34
42. Howell, A.L.; Taylor, T.H.; Miller, J.D.; Groveman, D.S.; Eccles, E.H.; Zacharski, L.R. Inhibition of HIV-1 infectivity by low molecular weight heparin. Results of in vitro studies and a pilot clinical trial in patients with advanced AIDS. Int. J. Clin. Lab. Res., 1996, 26(2), 124-131
43. Guo, Y.; Wang, Z.; Dong, L.; Wu, J.; Zhai, S.; Liu, D. Ability of low-molecular-weight heparin to alleviate proteinuria by inhibiting respiratory syncytial virus infection. Nephrology., 2008, 13(7), 545-553
44. Miceli, M.H.; Bernardo, S.M.; Ku, T.S.; Walraven, C.; Lee, S.A. In vitro analyses of the effects of heparin and parabens on Candida albicans biofilms and planktonic cells. Antimicrob. Agents Chemother., 2012, 56(1), 148-153
45. Leitgeb, A.M.; Blomqvist, K.; Cho-Ngwa, F.; Samje, M.; Nde, P.; Titanji, V.; Wahlgren, M. Low anticoagulant heparin disrupts Plasmodium falciparum rosettes in fresh clinical isolates. Am. J. Trop. Med. Hyg., 2011, 84(3), 390-396
46. Sim, J.S.; Hahn, B.S.; Im, A.R.; Park, Y.; Shin, J.E.; Bae, E.A.; Kim, D.H.; Kim, Y.S. Inhibition of Helicobacter pylori adhesion to Kato III cells by intact and low molecular weight acharan sulfate. Glycoconj. J., 2011, 28(6), 411-418
47. Pomin, V.H. Review: An overview about the structure-function relationship of marine sulfated homopolysaccharides with regular chemical structures. Biopolymers., 2009, 91(8), 601-609
48. Pomin, V.H.; Mourão, P.A. Structure, biology, evolution and medical importance of sulfated fucans and galactans. Glycobiology., 2008, 18(12), 1016-1027
49. Pomin, V.H. Fucanomics and galactanomics: marine distribution, medicinal impact, conceptions, and challenges. Mar. Drugs., 2012, 10(4), 793-811
50. Bilan, M.I.; Vinogradova, E.V.; Shashkov, A.S.; Usov, A.I. Structure of a highly pyruvylated galactan sulfate from the Pacific green alga Codium yezoense (Bryopsidales, Chlorophyta). Carbohydr. Res., 2007, 342(3-4), 586-596
51. Farias, E.H.; Pomin, V.H.; Valente, A.P.; Nader, H.B.; Rocha, H.A.; Mourão, P.A. A preponderantly 4-sulfated, 3-linked galactan from the green alga Codium isthmocladum. Glycobiology., 2008, 18(3), 250-259
52. Pomin, V.H. Structural and functional insights into sulfated galactans: a systematic review. Glycoconj. J., 2010, 27(1), 1-12
53. Adhikari, U.; Mateu, C.G.; Chattopadhyay, K.; Pujol, C.A.; Damonte, E.B.; Ray, B. Structure and antiviral activity of sulfated fucans from Stoechospermum marginatum. Phytochemistry., 2006, 67(22), 2474-2482
54. Feldman, S.C.; Reynaldi, S.; Stortz, C.A.; Cerezo, A.S.; Damont, E.B. Antiviral properties of fucoidan fractions from Leathesia difformis. Phytomedicine., 1999, 6(5), 335-340
55. Zapopozhets, T.S.; Besednova, N.N.; Loenko, IuN. Antibacterial and immunomodulating activity of fucoidan. Antibiot. Khimioter., 1995, 40(2), 9-13
56. Sakai, T.; Nakanishi, Y.; Kato, I.; Takesako, K. Antifungal containing fucoidan oligosaccharide composition. Japanese Patent, Application Number: JP2005000172193, 2005
57. Matsuhiro, B.; Conte, A.F.; Damonte, E.B.; Kolender, A.A.; Matulewicz, M.C.; Mejías, E.G.; Pujol, C.A.; Zúñiga, E.A. Structural analysis and antiviral activity of a sulfated galactan from the red seaweed Schizymenia binderi (Gigartinales, Rhodophyta). Carbohydr. Res., 2005, 340(15), 2392-2402
58. Ohta, Y.; Lee, J.B.; Hayashi, K.; Hayashi, T. Isolation of sulfated galactan from Codium fragile and its antiviral effect. Biol. Pharm. Bull., 2009, 32(5), 892-898
59. Duarte, M.E.; Cauduro, J.P.; Noseda, D.G.; Noseda, M.D.; Gonçalves, A.G.; Pujol, C.A.; Damonte, E.B.; Cerezo, A.S. The structure of the agaran sulfate from Acanthophora spicifera (Rhodomelaceae, Ceramiales) and its antiviral activity. Relation between structure and antiviral activity in agarans. Carbohydr. Res., 2004, 339(2), 335-347
60. Eccles, R.; Meier, C.; Jawad, M.; Weinmüllner, R.; Grassauer, A.; Prieschl-Grassauer, E. Efficacy and safety of anti-viral iotacarrageenan nasal spray: a randomized, double-blind, placebocontrolled exploratory study in volunteers with early symptoms of the common cold. Resp. Res., 2010, 11, 108
61. Tateda, K.; Irifune, K.; Shimoguchi, K.; Tomono, K.; Hirakata, Y., Matsumoto, T.; Kaku, M.; Yamaguchi, K. Potential activity of carrageenan to enhance antibacterial host-defense systems in mice. J. Infect. Chemother., 1995, 1(1), 59-63
62. Pierre, G.; Sopena, V.; Juin, C.; Mastouri, A.; Graber, M.; Maugard, T. Antibacterial activity of a sulfated galactan extracted from the marine alga Chaetomorpha aerea against Staphylococcus aureus. Biotech. Bioproc. Engin., 2011, 16(5), 937-945
63. Marudhupandi, T.; Kumar, T.T.A. Antibacterial effect of fucoidan from Sargassum wightii against the chosen bacterial pathogens. Inter. Curr. Pharm. J., 2013, 2(10), 156-158
64. Thompson, K.D.; Dragar, C. Antiviral activity of Undaria pinnatifida against herpes simplex virus. Phytother. Res., 2004, 18(7), 551-555
65. Lee, J.B.; Hayashi, K.; Hashimoto, M.; Nakano, T.; Hayashi, T. Novel antiviral fucoidan from sporophyll of Undaria pinnatifida (Mekabu). Chem. Pharm. Bull., 2004, 52(9), 1091-1094
66. Mandal, P.; Mateu, C.G.; Chattopadhyay, K.; Pujol, C.A.; Damonte, E.B.; Ray, B. Structural features and antiviral activity of sulphated fucans from the brown seaweed Cystoseira indica. Antivir. Chem. Chemother., 2007, 18(3), 153-162
67. Chen, J.H.; Lim, J.D.; Sohn, E.H.; Choi, Y.S.; Han, E.T. Growthinhibitory effect of a fucoidan from brown seaweed Undaria pinnatifida on Plasmodium parasites. Parasitol. Res., 2009, 104(2), 245-250
68. Maruyama, H.; Tanaka, M.; Hashimoto, M.; Inoue, M.; Sasahara, T. The suppressive effect of Mekabu fucoidan on an attachment of Cryptosporidium parvum oocysts to the intestinal epithelial cells in neonatal mice. Life Sci., 2007, 80(8), 775-781